🇮🇱 Lunsumio in Israel

Lunsumio (MOSUNETUZUMAB) regulatory status in Israel.

Marketing authorisation

MOH

  • Status: likely_approved

Lunsumio in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Israel

Frequently asked questions

Is Lunsumio approved in Israel?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Lunsumio in Israel?

Roche is the originator. The local marketing authorisation holder may differ — check the official source linked above.